Symbol
BioXcel Therapeutics, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$1.64
Current price of the stock
$92K
Trading volume of the stock
$4.3M
Market capitalization of the company
Nano Cap
Category of market capitalization
7.53%
Long-term growth mean estimate
3.71
Mean analyst rating
2196.71%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-1.22
Total debt to total equity ratio
1.87
Current ratio
-446.73%
Gross profit margin
-7146.26%
Operating profit margin
-7146.26%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-6378.50%
Pretax profit margin
-6378.50%
Net profit margin
15.94%
Measures profitability relative to shareholders' equity
15.94%
ROE excluding intangible assets
-27.92%
Measures profitability relative to total assets
-72.58%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
0.77
Inventory turnover ratio
71.33
Receivables turnover ratio
1.26
Average number of days it takes to collect receivables
-0.05
Measures valuation relative to earnings
-0.17
P/E based on future earnings estimates
1.91
Measures valuation relative to sales
-0.05
Measures valuation relative to book value
-0.01
Measures valuation relative to operating cash flow
-0.01
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
